Sean P. Nolan Taysha Gene Therapies, Inc. (TSHA) insider trading activity

Sean P. Nolan is Chief Executive Officer of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 2.91 Million shares of TSHA, which is worth approximately $12.2 Million. The most recent transaction as insider was on Jan 26, 2026, when has been sold 41,312 shares (Common Stock) at a price of $4.61 per share, resulting in proceeds of $190,448. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.91M

39.93% 3M change

39.93% 12M change

Total Value Held $12.2 Million

Sean P. Nolan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 26 2026	SELL Open market or private sale	$190,448 $4.61 p/Share	41,312 Reduced 1.4%	2,908,257 Common Stock
Jan 23 2026	SELL Open market or private sale	$649,747 $4.75 p/Share	136,789 Reduced 4.43%	2,949,569 Common Stock
Jan 12 2026	BUY Grant, award, or other acquisition	-	1,008,000 Added 24.62%	3,086,358 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	892,500 Added 30.04%	2,078,358 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	1,184,688 Added 49.98%	1,185,858 Common Stock
May 20 2021	BUY Open market or private purchase	$26,150 $22.35 p/Share	1,170 Added 50.0%	1,170 Common Stock

Also insider at

VTR

Ventas, Inc. Real Estate

Director

SPN

Sean P. Nolan

Chief Executive Officer

Chicago, IL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSHA shares.

Notify only if

Value

Insider Trading

Get notified when an Taysha Gene Therapies, Inc. insider buys or sells TSHA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Taysha Gene Therapies, Inc.

Track Activities on TSHA

Account